Table 2.
Proposed mechanisms of disease for hypoPP and possible potential future therapeutic developments
Pathomechanism | Target pathway | Potential therapy |
---|---|---|
Disrupted intracellular pH homeostasis | Possible role of intracellular carbonic anhydrases | Isoform-specific and membrane-permeable carbonic anhydrase inhibitors |
Gating pore leak | Aberrant cation permeability | Gating pore ‘blockers’ |
Inhibition of IRK channels | Reduced sarcolemmal potassium conductance | Potassium channel activators |